Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Total Debt / Capital

Gilead Sciences Inc Total Debt / Capital Chart (GILD)

Gilead Sciences Inc annual/quarterly Total Debt / Capital from 2010 to 2020.
  • Gilead Sciences Inc Total Debt / Capital for the quarter ending September 09, 2020 was $63m a 15.74% increase of 10m year over year
  • Gilead Sciences Inc Total Debt / Capital for the last 12 months ending September 09, 2020 was $63m a 15.74% increase of 10m year over year
  • Gilead Sciences Inc Annual Total Debt / Capital for 2019 was $53m a -5.95% decrease of -3m from 2018
  • Gilead Sciences Inc Annual Total Debt / Capital for 2018 was $56m a -10.98% decrease of -6m from 2017
  • Gilead Sciences Inc Annual Total Debt / Capital for 2017 was $62m a 7.13% increase of 4m from 2016
Other Ratios Metrics:
  • Gilead Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $6,612m a -11.19% decrease of -740m year over year
  • Gilead Sciences Inc Total Debt / Equity for the quarter ending December 12, 2018 was $146m a 3.93% increase of 6m year over year
View Chart On Koyfin

Quarterly GILD Total Debt / Capital Data

09/2020$63m
06/2020$57m
03/2020$52m
12/2019$53m
09/2019$55m
06/2019$54m
03/2019$55m
12/2018$56m
09/2018$54m
06/2018$57m

Annual GILD Total Debt / Capital Data

2019$53m
2018$56m
2017$62m
2016$58m
2015$54m
2014$44m
2013$36m
2012$46m
2011$53m
2010$36m